drugset / Trial / NCT00212004
Pioglitazone Protects Diabetes Mellitus (DM) Patients Against Re-Infarction (PPAR Study)
Phase 4
Terminated
630 enrolled
National Cerebral and Cardiovascular Center, Japan
Japan Heart Foundation · collab
RandomizedParallel-groupOpen-labelPrevention
Summary
To evaluate whether the pioglitazone could reduce the recurrence of myocardial infarction (MI) in patients with DM and old myocardial infarction
Timeline
- Start
- 2005-04
- Primary completion
- 2017-04
- Completion
- 2018-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Pioglitazone | Small molecule | 30 mg | — |